Steffen Moritz. santosacademyjapan.com Fakultät für Informatik und Ingenieurwissenschaften. Institut für Data Science, Engineering, and Analytics (IDE+A). Steffen Moritz. Campus. Dieses Selbsthilfemanual für Menschen mit Zwangsstörungen zeigt Betroffenen anhand zahlreicher unterhaltsamer Beispiele sowie bewährten und neuen. Steffen Moritz | Bonn, Nordrhein-Westfalen, Deutschland | + Kontakte | Vollständiges Profil von Steffen auf LinkedIn anzeigen und vernetzen.
Prof. Dr. Steffen Moritzsteffen moritz cv. Steffen Moritz | Bonn, Nordrhein-Westfalen, Deutschland | + Kontakte | Vollständiges Profil von Steffen auf LinkedIn anzeigen und vernetzen. Dieses Selbsthilfemanual für Menschen mit Zwangsstörungen zeigt Betroffenen anhand zahlreicher unterhaltsamer Beispiele sowie bewährten und neuen.
Steffen Moritz 116 contributions in the last year VideoFortunaTV-Interview - Steffen Moritz nach dem Testspiel beim VfL Osnabrück
Mindfulness predicts insight in obsessive-compulsive disorder over and above OC symptoms. Eine randomisiert-kontrollierte Studie [Can an online intervention for depression alleviate emotional problems and pain?
Early detection. A defense of our statement that we should not catastrophize a future we cannot reliably predict nor change. Imaginal retraining decreases craving for high-calorie food in overweight and obese women.
Post-psychotic depression. Does uncertainty breed conviction? Letter to the Editor: Metacognitive training and metacognitive therapy.
Metacognitive training. Cupitt C eds. New York: Routledge, Terapi metakognitif. Pada pasien skizofrenia dengan waham.
Ester M eds. Do guided internet-based interventions result in clinically relevant changes for patients with depression? Is self-guided internet-based cognitive behavioural therapy iCBT harmful?
Evaluation of a brief unguided psychological online intervention for depression. A meta-analysis" by Twomey and colleagues [Psychiatry Res.
We cannot change the past, but we can change its meaning. The stereotype threat effect: An alternative explanation for neurocognitive deficits in schizophrenia?
New wine in an old bottle? Decreased memory confidence in obsessive-compulsive disorder for scenarios high and low on responsibility: is low still too high?
Metacognition — What did James H. Who benefits and who does not? If it is absurd, then why do you do it? Dysfunction by Disclosure? Stress levels in psychosis: Do body and mind diverge?
Correction: Does a narcissism epidemic exist in modern western societies? Does a narcissism epidemic exist in modern western societies?
Individualized metacognitive therapy for delusions. Introduction to the special issue on cognition and delusions. What do we know, what do we guess, and what do we perhaps falsely believe?
Verhaltenstherapie in der Praxis. Brakemeier E, Jacobi F eds. Weinheim: Beltz, Would I take antipsychotics, if I had psychotic symptoms? Issy-les-Moulineaux : Elsevier Masson, Cognitive and metacognitive mechanisms of change in Metacognitive Training for Depression.
Does recruitment source moderate treatment effectiveness? Time to remission from mild to moderate depressive symptoms. Metakognitives Training.
Neurocognitive deficits or stress overload: Why do individuals with schizophrenia show poor performance in neurocognitive tests? Psychotherapie von Schizophrenie: Was geht?
Negative affect and a fluctuating jumping to conclusions bias predict subsequent paranoia in daily life.
Psychosocial approaches in the treatment of psychosis. The customer is always right? Muslims Love Jesus, Too? Do depressive symptoms predict paranoia or vice versa?
Does impairment in neuropsychological tests equal neuropsychological impairment in obsessive-compulsive disorder OCD?
Neurocognitive deficits in schizophrenia. Are we making mountains out of molehills? Liberale Akzeptanz als kognitiver Mechanismus bei Psychose.
A two-stage cognitive theory of the positive symptoms of psychosis. Are we exaggerating neuropsychological impairment in depression?
Untangling the complex relationships between symptoms of schizophrenia and emotion dynamics in daily life. Non-pharmacological interventions for schizophrenia: How much can be achieved and how?
Diagnostische Verfahren in der Psychotherapie. KG, Entwicklungen in der Integrativen KVT. Stavemann H eds. Erkennen und modifzieren von Denkverzerrungen.
Funktions- und störungsorientiertes Vorgehen. München: Elsevier GmbH, Should we focus on quality or quantity in meta-analyses?
More adaptive versus less maladaptive coping: What is more predictive of symptom severity? Overview Repositories 14 Projects 0 Packages.
Steffen Moritz SteffenMoritz. Block or report user Block or report SteffenMoritz. Block user Prevent this user from interacting with your repositories and sending you notifications.
Block user. Report abuse. Highlights Arctic Code Vault Contributor. If you are interested, please send an email with relevant attachments e.
Good command of the German language is advantageous. Click to enlarge. Meta-analyses show efficacy of metacognitive training for psychosis MCT Two meta-analyses show that patients with psychosis benefit significantly from our metacognitive training for psychosis MCT compared to a control group in terms of positive symptoms.
Profile Our working group is engaged in the assessment, diagnosis, and treatment of psychiatric disorders. Our Team Our Team Our Team Research We conduct research on a variety of psychiatric diseases, including schizophrenia, obsessive-compulsive disorder, depression, and borderline personality disorder, in collaboration with our German and international research partners.
Should such side effects remain undetected by clinicians and not be adequately dealt with, patients are likely to discontinue drug intake, deciding the side effects outweigh the benefit of drug treatment.
Secondly, noncompliance can result from forgetting Fenton et al. Because of its impact on psychopathology, functional outcome and treatment-related variables, the amelioration of neurocognitive deficits is increasingly considered a target domain of antipsychotic treatment.
The majority of studies conducted to date have shown that typical antipsychotics have a negligible impact on most neurocognitive functions.
However, verbal fluency e. Some of the results indicating stable cognitive functioning with conventional medications may in fact obscure real cognitive decline since patients' overall health state generally normalizes over the course of clinical trials and improved psychopathology in turn is often accompanied by modest neurocognitive improvement.
See Moritz et al. Moreover, familiarity with the assessment procedures and practice effects also predicts some increase in achievement even without real change.
In addition, the induction of extrapyramidal side effects due to the administration of conventional D 2 antagonists often necessitates prescription of anticholinergic medication, which, as outlined, has negative effects on learning and memory.
Taken together, the conventional "treatment package" D 2 antagonists and anti-Parkinson agents potentially harms the already decreased cognitive capacity of patients with schizophrenia.
With the possible exception of clozapine Clozaril , for which divergent findings have been collected with respect to memory, studies investigating the efficacy of atypical antipsychotic agents have mostly found enhancing effects on neurocognition Keefe et al.
Although there is evidence that atypical antipsychotics directly exert beneficial effects on neurocognitive functioning, some of the positive effects of atypical antipsychotics on neurocognition stem from a more pronounced remission of negative symptoms relative to conventional agents.
The positive impact of atypical antipsychotics on neurocognitive functioning embraces the domains of memory short- and long-term , selective attention, executive functioning and verbal fluency Bilder et al.
As spatial processing rarely has been assessed, no solid conclusions can yet be drawn regarding this domain Moritz, In recent years, studies employing standard neurocognitive tests have been complemented by research on subjective cognitive complaints in patients.
The assessment of subjective cognitive well-being is by no means redundant to objective testing since subjective and objective testing are often poorly correlated Moritz et al.
The assessment of subjective cognitive deficits offers a means to circumvent simple practice effects that plague studies that have objective neurocognitive tests but no control groups.
In two studies, subjective cognitive deficits predicted later symptomatic outcome in first-episode patients, further highlighting the importance of subjective complaints Moritz et al.
In addition, Naber found that well-being at discharge as assessed by the Subjective Well-Being Under Neuroleptic Treatments questionnaire SWN , which also incorporates a mental functioning scale, predicted compliance at follow-up.
In one of the first studies that investigated subjective cognitive deficits, patients with schizophrenia reported fewer subjective cognitive complaints after treatment with clozapine in comparison to haloperidol Haldol Morgner, Differences were largest for the subscales of motor functioning and loss of automation on the Frankfurt Complaint Questionnaire FCQ Sllwold, Metacognitive control over false memories: a key determinant of delusional thinking.
The contribution of metamemory deficits to schizophrenia. Investigation of metamemory dysfunctions in first-episode schizophrenia.
Incautious reasoning as a pathogenetic factor for the development of psychotic symptoms in schizophrenia. Patients with schizophrenia do not produce more false memories than controls but are more confident in them.
Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome. Dissociation as a predictor of cognitive behavior therapy outcome in patients with obsessive-compulsive disorder.
Childhood trauma and dissociation in female patients with schizophrenia spectrum disorders: an exploratory study.
Increased hindsight bias in schizophrenia. The contribution of a cognitive bias against disconfirmatory evidence BADE to delusions: a study in an Asian sample with first episode schizophrenia spectrum disorders.
The contribution of a cognitive bias against disconfirmatory evidence BADE to delusions in schizophrenia. Posttraumatic stress disorder and memory problems after female genital mutilation.
PANSS syndromes and quality of life in schizophrenia. The impact of substance use disorders on clinical outcome in patients with first-episode psychosis.
Investigation of mood-congruent false and true memory recognition in depression. Neurocognitive impairment does not predict treatment outcome in obsessive-compulsive disorder.
Extent, profile and specificity of visuospatial impairment in obsessive-compulsive disorder OCD. Quality of life in obsessive-compulsive disorder before and after treatment.
Inhibition of return in patients with obsessive-compulsive disorder. Jumping to conclusions in delusional and non-delusional schizophrenic patients.
Confidence in errors as a possible basis for delusions in schizophrenia. Randomized double blind comparison of olanzapine vs.
Late-onset depression with mild cognitive deficits: electrophysiological evidences for a preclinical dementia syndrome. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.
Pharmacotherapy of schizophrenia spectrum disorders. Schizophrenia Psychiatry Textbook. Naber D, Lambert M Hrsg.
Georg Thieme Verlag KG, Reduced negative priming in schizotypy: failure to replicate. Memory and attention performance in psychiatric patients: lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results.
Positive schizotypal symptoms predict treatment outcome in obsessive-compulsive disorder. Task switching and backward inhibition in obsessive-compulsive disorder.
Examination of emotional Stroop interference in obsessive-compulsive disorder. Neurocognition under conventional and atypical neuroleptics - a critical review.
Kognition und Schizophrenie - Biopsychosoziale Konzepte. Lasar M, Goldbeck F Hrsg. Lengerich: Pabst, Dimensional structure of the Hamilton Depression Rating Scale in patients with obsessive-compulsive disorder.
False memories in schizophrenia. Material-specific episodic memory associates of the psychomotor poverty syndrome in schizophrenia. Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of patients with schizophrenia spectrum disorders.
Reliable change indexes for memory performance in schizophrenia as a means to determine drug-induced cognitive decline.
Neurokognition unter konventionellen und atypischen Neuroleptika: eine methodenkritische Übersicht. Laser M, Goldbeck F Hrsg.
Impact of comorbid depressive symptoms on nonverbal memory and visuospatial performance in obsessive-compulsive disorder.
Increased automatic spreading of activation in thought-disordered schizophrenic patients. Source monitoring and memory confidence in schizophrenia.
Methodological considerations regarding the association of Stroop and verbal fluency performance with the symptoms of schizophrenia. Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients.
Psychiatry textbook. Naber D Hrsg. Neurocognitive performance in first-episode and chronic schizophrenic patients. Executive functioning in obsessive-compulsive disorder, unipolar depression, and schizophrenia.
Subjective cognitive dysfunction in first-episode patients predicts symptomatic outcome: a replication.
Memory confidence and false memories in schizophrenia. Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication.
The schizoid personality disorder: should we consider a differentiation from schizotype personality disorder?
Psychometric evolution and biopsychological research.. Andresen B, Mass R Hrsg. Hogrefe, Quetiapine Seroquel - a new atypical antipsychotic in the treatment of schizophrenia.
Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics. Impact of comorbid depressive symptoms on neuropsychological performance in obsessive-compulsive disorder.
Further evidence for delayed alternation deficits in obsessive-compulsive disorder. An analysis of the specificity and the syndromal correlates of verbal memory impairments in schizophrenia.Good news for allegedly bad studies. Spin De Einloggen, K. Depressivität als Moderator neurokognitiver Störungen bei Zwangserkrankten. Material-specific episodic memory associates of the psychomotor poverty syndrome in schizophrenia. Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with Oshi depression: a longitudinal study.